![STORM trial results at ESTRO 24](https://oncodaily.com/pub/uploads/2024/08/GTPKtlEWUAALH_Z-e1724140723637.jpeg)
Photo from ESTRO/X
Aug 21, 2024, 14:23
STORM trial results at ESTRO 24
ESTRO shared on X:
“STORM trial results on the treatment of pelvic nodal oligo-recurrence after Prostate Cancer, presented at ESTRO 24: ENRT improves biochemical and locoregional relapse-free survival rates compared with SBRT.”
Further information.
Source: ESTRO/X
Other posts Featuring ESTRO on OncoDaily.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 10, 2025, 18:24
Feb 10, 2025, 18:17
Feb 10, 2025, 16:49
Feb 10, 2025, 16:08
Feb 10, 2025, 15:56